Skip to main content

Brain damage tied to thinking differs by sex in MS

By MS Buddy ·

Summarized from Molecular psychiatry, Apr 2023 · PubMed · DOI. AI-generated summary. Not medical advice.

Observational study · 459 people with relapsing or progressive MS and healthy volunteers

Research by Nicolò Tedone, Maria Rocca and 5 colleagues at IRCCS San Raffaele Scientific Institute in Italy.

Does brain damage relate to thinking problems differently in men and women with MS?

Key Takeaway

Men and women with MS had similar rates of thinking problems, but brain damage linked to test scores differed by sex.

Two faceless figures hold matching incomplete puzzles beneath brain shapes with different muted patches.
Credibility
Interest
Share:1 min read

What They Found

About 38% of women and 42% of men with MS had thinking problems, a difference the researchers did not consider meaningful. Men did worse on verbal memory tests, while women did worse on tests of finding words. In both groups, more damage to brain pathways was linked to worse thinking test scores. This link was stronger in women on tests of overall thinking ability. Loss of brain tissue linked to worse scores appeared mainly in different areas for men and women.

Who Should Care and Why

The study included people with MS and healthy volunteers. People with MS had either relapsing-remitting MS or progressive MS. Researchers compared brain scans from both groups. Only the people with MS took the thinking tests described in the abstract. The findings describe how brain scan changes relate to thinking test scores in men and women with MS.

Important Considerations

You should know this was a study of brain scans and test scores, not a treatment trial. It included 287 people with MS and 172 healthy volunteers. These links do not show that the brain changes caused the thinking problems.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Molecular psychiatry by et al.. Reproduced from the PubMed record.

In this study, we investigated whether regional distribution of white matter (WM) lesions, normal-appearing [NA] WM microstructural abnormalities and gray matter (GM) atrophy may differently contribute to cognitive performance in multiple sclerosis (MS) patients according to sex. Using the same scanner, brain 3.0T MRI was acquired for 287 MS patients (females = 173; mean age = 42.1 [standard deviation, SD = 12.7] years; relapsing-remitting = 196, progressive = 91; median Expanded Disability Status Scale = 2.5 [interquartile range, IQR = 1.5-5.0]; median disease duration = 12.1 [IQR = 6.3-19.0] years; treatment: none = 70, first-line = 130, second-line = 87) and 172 healthy controls (HC) (females = 92; mean age = 39.3 [SD = 14.8] years). MS patients underwent also Rao's neuropsychological battery. Using voxel-wise analyses, we investigated in patients sex-related differences in the association of cognitive performances with WM lesions, NAWM fractional anisotropy (FA) and GM volumes (p < 0.01, family-wise error [FWE]). Sixty-six female (38%) and 48 male (42%) MS patients were cognitively impaired, with no significant between-group difference (p = 0.704). However, verbal memory performance was worse in males (p = 0.001), whereas verbal fluency performance was worse in females (p = 0.004). In both sexes, a higher T2-hyperintense lesion prevalence in cognitively-relevant WM tracts was significantly associated with worse cognitive performance (p ≤ 0.006), with stronger associations in females than males in global cognition (p ≤ 0.004). Compared to sex-matched HC, male and female MS patients had widespread lower NAWM FA and GM volume (p < 0.01). In both sexes, worse cognitive performance was associated with widespread reduced NAWM FA (p < 0.01), with stronger associations in females than males in global cognition and verbal memory (p ≤ 0.009). Worse cognitive performance was significantly associated with clusters of cortical GM atrophy in males (p ≤ 0.007) and mainly with deep GM atrophy in females (p ≤ 0.006). In this study, only limited differences in cognitive performances were found between male and female MS patients. A disconnection syndrome due to focal WM lesions and diffuse NAWM microstructural abnormalities seems to be more relevant in female MS patients to explain cognitive impairment.

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

A winding blue paper path curves around ochre shapes toward a resting circle bordered by an incomplete paper ring.
MS fatigue may reflect extra effort to control movement

11/17/2026

A review suggests MS fatigue may reflect extra effort to control movement and incomplete recovery af

Read More
Two paper patchwork circles have similar overall colors but different pieces, with folds hiding or revealing layers.
Computer studies show MS fatigue surveys differ by person

11/16/2026

Computer studies found MS fatigue surveys can give similar group results but different individual sc

Read More
Three soft ribbons in muted clay, sage and blue follow varied, loosely overlapping paths on an off-white background.
Exercise and coping programs helped fatigue in MS review

11/17/2026

A review found exercise, therapy focused on thoughts and behavior, and self-management programs show

Read More
Navy nerve-like lines meet at a central junction, with gaps in their ochre protective sleeves.
MS tissue and mice show damage in a brain vision hub

11/17/2026

Donated MS brain tissue showed damage in a vision hub. Mouse findings linked local immune cell activ

Read More
A blue brain outline beside two loosely intertwined blue and ochre paths with varying space between them.
Thinking problems linked to sexual difficulties in MS

1/1/2026

A study of 318 people with MS linked lower thinking test scores to more sexual difficulties, with th

Read More
Brain outline filled with fine, branching nerve fibers on an off-white background.
In relapsing MS, Mavenclad users' thinking scores rose

11/14/2026

In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.